Somatuline LA: a new treatment for acromegaly

Somatostatin analogues have become well established as treatment for acrome galy. However, to ensure growth hormone (GH) levels are sufficiently suppre ssed, thrice daily subcutaneous injections am required. The introduction of Somatuline LA, a long acting formulation which controls plasma GH levels f or up ro 14 days and improves acromegaly symptoms, is likely to improve pat ient compliance and quality of life.